David Duski is a panelist during the session discussing the complexities and nuances of trade secrets damages.
For more information on this event, click here.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
David Duski is a panelist during the session discussing the complexities and nuances of trade secrets damages.
For more information on this event, click here.
We are pleased to present the latest edition of CRA’s IP Literature Watch. This issue contains pieces on antitrust & IP, licensing, litigation, innovation, law...
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
